10-Q: Q3 2024 Earnings Report
8-K: Biote Reports Third Quarter 2024 Financial Results Continued Profitable Growth Vertical integration drives gross profit margin improvement Launch of proprietary clinical decision support software to strengthen competitive advantages
10-Q: Q2 2024 Earnings Report
8-K: Biote Reports Second Quarter 2024 Financial Results Procedure revenue growth accelerates sequentially BioteRx roll-out on track with further expansion planned Management reiterates 2024 financial guidance
10-Q: Q1 2024 Earnings Report
BIOTE CORP C/WTS 26/05/2027 (TO PUR COM) | 10-K: Annual report
BIOTE CORP C/WTS 26/05/2027 (TO PUR COM) | 10-Q: Quarterly report
BIOTE CORP C/WTS 26/05/2027 (TO PUR COM) | 8-K: Biote Reports Third Quarter 2023 Financial Results Achieves Progress in Test of Complementary Wellness Therapeutics Reiterates 2023 Financial Guidance
BIOTE CORP C/WTS 26/05/2027 (TO PUR COM) | 10-Q: Quarterly report
BIOTE CORP C/WTS 26/05/2027 (TO PUR COM) | 8-K: Biote Reports Second Quarter 2023 Financial Results Solid Second Quarter Revenue Growth Continued Progress to Optimize Capital Structure and Enhance Share Liquidity Expansive Strategic Approach Targeting Ther
BIOTE CORP C/WTS 26/05/2027 (TO PUR COM) | 10-Q: Quarterly report
BIOTE CORP C/WTS 26/05/2027 (TO PUR COM) | 8-K: Biote Reports First Quarter 2023 Financial Results New Initiative Targets Long-term Growth Opportunity in Mens Health Company Launches Warrant Exchange Offer and Consent Solicitation Maintains 2023 Financial
BIOTE CORP C/WTS 26/05/2027 (TO PUR COM) | 10-K: Annual report
BIOTE CORP C/WTS 26/05/2027 (TO PUR COM) | 10-Q/A: Quarterly report (Amendment)
BIOTE CORP C/WTS 26/05/2027 (TO PUR COM) | 10-Q/A: Quarterly report (Amendment)
BIOTE CORP C/WTS 26/05/2027 (TO PUR COM) | 10-Q: Quarterly report
BIOTE CORP C/WTS 26/05/2027 (TO PUR COM) | 8-K: Biote Reports Third Quarter Financial Results Strong Third Quarter Revenue of $42 million Driven by Growth in Procedures 2022 Revenue and Adjusted EBITDA Expected at Upper End of Guidance
BIOTE CORP C/WTS 26/05/2027 (TO PUR COM) | 10-Q: Quarterly report
BIOTE CORP C/WTS 26/05/2027 (TO PUR COM) | 8-K: Biote Reports Second Quarter 2022 Financial Results
BIOTE CORP C/WTS 26/05/2027 (TO PUR COM) | 10-Q: Quarterly report
No Data
No Data